The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage

Huang, Y-HY-HHuangChen, C-HC-HChenChang, T-TT-TChangSHU-CHING CHENChiang, J-HJ-HChiangLee, H-SH-SLeeLin, P-WP-WLinGUAN-TARN HUANGSheu, J-CJ-CSheuTsai, H-MH-MTsaiLee, P-CP-CLeeHuo, T-IT-IHuoLee, S-DS-DLeeWu, J-CJ-CWu2024-03-262024-03-262005-03-150269-2813https://www.scopus.com/record/display.uri?eid=2-s2.0-20144388849&doi=10.1111%2fj.1365-2036.2005.02404.x&origin=inward&txGid=add2b5ae37b079640a0370877ca4f16fhttps://scholars.lib.ntu.edu.tw/handle/123456789/641384Transcatheter arterial embolization is a major palliative treatment for unresectable hepatocellular carcinoma, but the survival benefit of transcatheter arterial embolization is controversial.en[SDGs]SDG3The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stagejournal article10.1111/j.1365-2036.2005.02404.x157717542-s2.0-20144388849https://api.elsevier.com/content/abstract/scopus_id/20144388849